文献速递临床试验与 GCP

高流量鼻导管氧疗与室内空气对择期剖宫产产妇胎儿酸血症影响的随机对照试验研究方案

Effect of maternal oxygen supplementation for parturient undergoing elective cesarean section by high-flow nasal oxygen compared with room air on fetal acidemia: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2024-01-22

这项前瞻性、单中心、随机、双盲试验将纳入120例择期剖宫产产妇,按1:1随机分为高流量鼻导管氧疗(HFNO)组与空气组,比较脐动脉乳酸等指标,以探讨母体氧补充对胎儿酸血症的影响。

要点

  • HFNO组流量40 L/min、加温至37℃、湿度100%氧浓度;空气组流量2 L/min。
  • 主要结局为脐动脉乳酸,次要结局包括脐动脉pH、PO2、PCO2、BE等。
  • 这是首个探讨HFNO母体氧补充对剖宫产胎儿酸血症影响的试验。

核心结论

  • 本研究旨在确定剖宫产期间通过HFNO进行母体氧补充是否对胎儿酸血症有积极作用。
  • 作者称这是首个探讨HFNO母体氧补充能否降低剖宫产产妇脐动脉乳酸水平及胎儿酸血症发生率的试验。

研究设计与样本

  • 前瞻性、单中心、随机、双盲试验,计划纳入120例择期剖宫产产妇。
  • 参与者按1:1比例随机分配至高流量鼻导管氧疗(HFNO)组或空气组。

主要发现

  • HFNO组流量为40 L/min,氧气经Optiflow高流量鼻导管氧疗系统加温至37℃、湿度100%氧浓度。
  • 空气组通过同一装置以空气模式给气,流量为2 L/min。
  • 主要结局为脐动脉(UA)乳酸。
  • 次要结局包括脐动脉pH、PO2、PCO2、BE、pH<7.20和pH<7.10的发生率、1分钟和5分钟Apgar评分及新生儿不良结局。

关键数值与推荐

  • 原文未报告结果数值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal oxygen supplementation is usually used as an intrauterine resuscitation technique to prevent fetal hypoxia and acidemia during delivery. However, there has been a great deal of controversy regarding the effects of prophylactic maternal oxygen during cesarean section, during which the incidence of fetal acidemia seems to be higher compared with that during labor. High-flow nasal oxygen (HFNO) can improve oxygenation better in patients with high-flow oxygen airflow. The purpose of this study is to determine whether maternal oxygen supplementation with HFNO has a positive effect on fetal acidemia during cesarean section through umbilical arterial blood gas analysis. METHOD: This prospective, single-center, randomized, double-blinded trial will enroll 120 patients undergoing cesarean section. Participants will be randomly assigned to the HFNO group or air group at a 1:1 ratio. For parturients in the HFNO group, the flow rate is 40L/min, and the oxygen is heated to 37℃ with humidity 100% oxygen concentration through the Optiflow high-flow nasal oxygen system. And for the air group, the flow rate is 2 L/min with an air pattern through the same device. The primary outcome was umbilical artery (UA) lactate. Secondary outcomes include UA pH, PO2, PCO2, BE, the incidence of pH < 7.20 and pH < 7.10, Apgar scores at 1 and 5 min, and neonatal adverse outcomes. DISCUSSION: Our study is the first trial investigating whether maternal oxygen supplementation with HFNO can reduce the umbilical artery lactate levels and the incidence of fetal acidemia in cesarean section under combined spinal-epidural anesthesia. TRIAL REGISTRATION: ClinicalTrials.gov NCT05921955. Registered on 27 June 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li YH, Lei GY, Guo J, et al. Effect of maternal oxygen supplementation for parturient undergoing elective cesarean section by high-flow nasal oxygen compared with room air on fetal acidemia: study protocol for a randomized controlled trial. Trials. 2024. PMID: 38254137. doi:10.1186/s13063-024-07927-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。